Mark Lloyd
- Pathology and Forensic Medicine top 10%
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 3
-
- Inhalation and Respiratory Drug Delivery 7
- Respiratory and Cough-Related Research 4
- Vasculitis and related conditions 4
-
- Asthma and respiratory diseases 11
-
- Inflammatory Myopathies and Dermatomyositis 3
-
- Turtle Biology and Conservation 3
-
- Immunodeficiency and Autoimmune Disorders 3
- Co-authors
- Aaron CranstonTeresa WilsonMark MeuthHong ZhangAndrew ThorburnRichard FishelBurt T. RichardsDonald Banerji
- Journals
- Journal of Allergy and Clinical Immunology (9 papers)Lara D. Veeken (9 papers)Journal of the Royal Society of Medicine (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Mark Lloyd
41 papers receiving 488 citations
Peers
Comparison fields: 5 of 94
- Pathology and Forensic Medicine 150
- Rheumatology 104
- Pulmonary and Respiratory Medicine 146
- Physiology 110
- Cancer Research 60
Countries citing papers authored by Mark Lloyd
This map shows the geographic impact of Mark Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lloyd more than expected).
Fields of papers citing papers by Mark Lloyd
This network shows the impact of papers produced by Mark Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lloyd. The network helps show where Mark Lloyd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Lloyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 4 | |
| 4 | 2019 | 15 | |
| 5 | 2016 | 0 | |
| 6 | Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis. | 2014 | 31 |
| 7 | 2014 | 1 | |
| 8 | Cytotoxic activity and Antioxidant Potentials of hexane and Methanol extracts of IR64 Rice bran against Human Lung (A549) and Colon (HCT116) Carcinomas | 2013 | 3 |
| 9 | 2012 | 1 | |
| 10 | 2006 | 1 | |
| 11 | 2006 | 5 | |
| 12 | 2005 | 3 | |
| 13 | 2005 | 68 | |
| 14 | 2005 | 56 | |
| 15 | 2004 | 0 | |
| 16 | 2002 | 4 | |
| 17 | 2002 | 13 | |
| 18 | 1997 | 2 | |
| 19 | Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. | 1995 | 35 |
| 20 | 1994 | 17 |
About Mark Lloyd
Mark Lloyd is a scholar working on Anatomy, Rheumatology, Physiology, Pulmonary and Respiratory Medicine and Rehabilitation, having authored 50 papers that have together received 522 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (7 papers), Respiratory and Cough-Related Research (4 papers), Vasculitis and related conditions (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Systemic Lupus Erythematosus Research (3 papers), Turtle Biology and Conservation (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (150 citations), Rheumatology (104 citations), Pulmonary and Respiratory Medicine (146 citations), Physiology (110 citations) and Cancer Research (60 citations). Mark Lloyd has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Aaron Cranston, Teresa Wilson, Mark Meuth, Hong Zhang, Andrew Thorburn, Richard Fishel, Burt T. Richards, Donald Banerji, Chris Fife‐Schaw and Shashank Rohatagi. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Lara D. Veeken, Journal of the Royal Society of Medicine, Clinical Medicine and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.